Nicholas Investment Partners, LP Instil Bio, Inc. Transaction History

Nicholas Investment Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $2.11 Million - $3.34 Million	453,824 Added 102.31%	897,386 $4.34 Million
Q2 2022 Aug 10, 2022	SELL	$4.21 - $11.15 $1.34 Million - $3.55 Million	-318,826 Reduced 41.82%	443,562 $2.05 Million
Q1 2022 May 10, 2022	BUY	$8.48 - $18.1 $416,936 - $889,922	49,167 Added 6.89%	762,388 $8.2 Million
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $523,348 - $766,125	34,050 Added 5.01%	713,221 $12.2 Million
Q3 2021 Nov 15, 2021	SELL	$15.05 - $23.28 $2.61 Million - $4.04 Million	-173,648 Reduced 20.36%	679,171 $12.1 Million
Q2 2021 Aug 10, 2021	BUY	$15.31 - $24.63 $4.64 Million - $7.47 Million	303,232 Added 55.17%	852,819 $16.5 Million
Q1 2021 May 14, 2021	BUY	$24.23 - $27.06 $13.3 Million - $14.9 Million	549,587 New	549,587 $13.8 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.